Abstract
Objective: To determine the specificity of the Abbott Murex HIV antigen/antibody combination enzyme immunoassay (EIA) for the diagnosis of HIV infection in Tanzania. Methods: A cross-sectional survey of 7333 Tanzanian adolescents and young adults was carried out. Sera testing positive by the Murex assay were further evaluated using a battery of other EIA which detect either antibody to HIV-1 or p24 antigen, and by PCR using pol primers. Results: Of the 674 sera testing positive by the Murex assay, only 53 (7.9%) were confirmed. The specificity of the Murex assay was 91.5%. Conclusions: Serological tests for HIV may perform differently in different populations. New diagnostic tests should not be introduced into populations in which they have not been evaluated.
| Original language | British English |
|---|---|
| Pages (from-to) | 1323-1326 |
| Number of pages | 4 |
| Journal | Tropical Medicine and International Health |
| Volume | 12 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Africa
- False positives
- HIV tests
- Specificity
Fingerprint
Dive into the research topics of 'Low specificity of the Murex fourth-generation HIV enzyme immunoassay in Tanzanian adolescents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver